Nasus Pharma Ltd
NYSE · Healthcare · Pharmaceutical Preparations · Tel Aviv - Yafo, Israel
NSRX chart
What traders are saying about $NSRX
Latest postsNasus Pharma Ltd news
- Nasus Pharma Ltd. Estimates – AMEX:NSRX
TradingView ·
- Nasus Pharma Announces Enrollment and Dosing of First Patient in Phase 1 Study of NS003 Intranasal Formulation of Ondansetron
Yahoo Finance ·
- Nasus Pharma Announces FDA Clearance to Initiate Clinical Study of NS002 in the Treatment of Anaphylaxis
Yahoo Finance ·
- Nasus Pharma to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Yahoo Finance ·
- NSRX: First Half 2026 Financial Results
Yahoo Finance ·
- Nasus Pharma Announces Transition of Chief Financial Officer
Yahoo Finance ·
- Nasus Pharma Reports First Half 2026 Financial Results and Provides Business Update
Yahoo Finance ·
- Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O'Grady as Chief Executive Officer to Lead Strategic Growth
Yahoo Finance ·
- OTC Markets Life Sciences Investor Forum: Dan Teleman, CEO, and Eyal Rubin, SVP and CFO, of Nasus Pharma with Zacks SCR's John Vandermosten, CFA
Yahoo Finance ·
- Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
Yahoo Finance ·
- Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
Yahoo Finance ·
- Nasus Pharma Announces Positive Results from Preclinical Pharmacokinetic and Safety Study of Intranasal Ondansetron (NS003)
Yahoo Finance ·
Nasus Pharma Ltd key financials
| USD | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | $1.24B | – | – |
| Net income | -$5.9M | -$1.5M | -$1.1M |
| Diluted EPS | $-0.72 | $-0.22 | $-0.20 |
| Total assets (year end) | $5.0M | $717,000 | – |
| Cash and equivalents (year end) | $1.2M | $284,000 | $193,000 |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Nasus Pharma Ltd
- Ticker
- NSRX (NYSE)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Tel Aviv - Yafo, Israel
- Incorporated in
- Israel
- Fiscal year end
- December 31
- SEC CIK
- 2029039
Frequently asked questions
What exchange is Nasus Pharma Ltd listed on?
Nasus Pharma Ltd trades on the NYSE under the ticker symbol NSRX.
What industry is Nasus Pharma Ltd in?
Nasus Pharma Ltd is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Nasus Pharma Ltd headquartered?
Nasus Pharma Ltd's business address on file with the SEC is in Tel Aviv - Yafo, Israel.
When does Nasus Pharma Ltd's fiscal year end?
Nasus Pharma Ltd's fiscal year ends on December 31.
How much revenue did Nasus Pharma Ltd report?
Nasus Pharma Ltd reported $1.24B in revenue for calendar year 2025, according to its SEC filings.